Related Experiment Video

Updated: Jul 14, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Electronic prescribing systems in pediatrics: the rationale and functionality requirements

, Robert S Gerstle

    Pediatrics
    |June 5, 2007
    PubMed

    Insights

    Encouraging electronic prescribing in pediatrics is vital. Policies should support adoption by addressing unique pediatric needs and economic factors, promoting research for system improvements.

    Area of Science:

    • Health Informatics
    • Pediatric Healthcare
    • Health Policy

    Background:

    • Electronic prescribing (e-prescribing) systems are recommended by national health organizations for improving patient care.
    • Pediatric practice presents unique challenges for e-prescribing adoption and effectiveness.
    • Federal recommendations and healthcare improvement initiatives advocate for e-prescribing implementation.

    Framework:

    • Legislation and policies are crucial to foster the adoption of e-prescribing systems in pediatrics.
    • Incentives should consider both specific pediatric requirements and general economic factors.
    • A framework supporting pediatrician adoption is necessary for successful implementation.

    Implementation:

    • Encouraging the use of electronic prescribing applications in pediatric settings is a key objective.
    • Addressing pediatric-specific needs within e-prescribing systems is essential for effective use.
    • Economic incentives can accelerate the adoption rate among pediatricians.

    Implications:

    • Continued research is needed to enhance e-prescribing effectiveness in pediatric populations.
    • Improved e-prescribing systems can lead to better health outcomes for children.
    • Successful adoption of e-prescribing supports national healthcare improvement goals.

    Related Concept Videos

    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
    Methods of Documentation VII: EMR01:30

    Methods of Documentation VII: EMR

    Electronic Medical Records (EMRs) primarily center around electronically documenting patients' health information within a single healthcare organization or practice. They contain essential clinical data related to a patient's medical history, diagnoses, medications, treatment plans, lab results, and other pertinent information relevant to the specific encounter or episode of care. EMRs are designed to streamline documentation and workflow processes within individual healthcare settings,...